Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT05585411

PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial

Led by Yonsei University · Updated on 2026-01-05

450

Participants Needed

8

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

PROTECT-SYNC study is a multicenter, randomized, controlled trial. A total of 7 medical centers across Republic of Korea will enroll 450 patients during 2 years of enrollment period, and followed for 2 years of follow-up period. The purpose of this study to compare the clinical outcomes of Left Bundle Branch Area Pacing (LBBAP) compared to Right Ventricular Pacing (RVP) in bradyarrhythmia patients who require high burden of ventricular pacing (\>40%).

CONDITIONS

Official Title

PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 19 years old and able to give informed consent
  • Willing and able to comply with follow-up tests and evaluation schedules
  • Scheduled to receive a pacemaker implant
  • Expected to require substantial ventricular pacing (>40%)
Not Eligible

You will not qualify if you...

  • Incapacitated or unable to read or write
  • Indicated for implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT)
  • History of prosthetic valve surgery on the tricuspid valve
  • Prior myocardial infarction including ventricular septum
  • Life expectancy less than 12 months due to any condition
  • Unavailable for at least 24 months of follow-up visits
  • Pregnant or breastfeeding at the time of consent
  • Prior heart transplant surgery
  • Persistent Left Superior Vena Cava (PLSVC)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Bucheon Sejong Hospital

Bucheon-si, South Korea

Actively Recruiting

2

GyeongSang National University Changwon Hospital

Changwon, South Korea

Actively Recruiting

3

Chungbuk National University Hospital

Chungju, South Korea

Actively Recruiting

4

Asan Medical Center

Seoul, South Korea

Actively Recruiting

5

Kyunghee University hospital

Seoul, South Korea

Actively Recruiting

6

Seoul National University Hospital

Seoul, South Korea

Actively Recruiting

7

Seoul Saint Mary's Hospital

Seoul, South Korea

Actively Recruiting

8

Yonsei University Health System, Severance Hospital

Seoul, South Korea

Not Yet Recruiting

Loading map...

Research Team

T

TaeHoon Kim

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here